ENDOTHELIAL DYSFUNCTION, REDOX-POTENTIAL SYSTEMS OF ENERGY SUPPLY AND ALDOSTERONE SYNTHESIS IN CHRONIC HEART FAILURE WITH AND WITHOUT ATRIAL FIBRILLATION

ENDOTHELIAL DYSFUNCTION, REDOX-POTENTIAL SYSTEMS OF ENERGY SUPPLY AND ALDOSTERONE SYNTHESIS IN CHRONIC HEART FAILURE WITH AND WITHOUT ATRIAL FIBRILLATION

Endothelial dysfunction, redox-potential systems of energy supply and aldosterone synthesis in chronic heart failure with and without atrial fibrillation.

Bibliographic Details
Main Authors:	N. V. Karsanov, G. V. Sukoyan, I. K. Kavadze, N. V. Salibegashvili, I. V. Golovach
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2003-08-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1765

Similar Items

Blood aldosterone level in various types of atrial fibrillation
by: N. T. Vatutin, et al.
Published: (2016-02-01)

GALECTIN 3 AND ALDOSTERONE IN PATIENTS WITH ATRIAL FIBRILLATION AND METABOLIC SYNDROME
by: V. A. lonin, et al.
Published: (2015-04-01)

Atrial fibrillation in primary aldosteronism
by: Timothy Watson, et al.
Published: (2009-12-01)

The role of aldosterone in the development of atrial fibrillation: modern understanding of problem
by: N. T. Vatutin, et al.
Published: (2019-03-01)

Endothelial dysfunction in patients with lone atrial fibrillation
by: Kiyan Heshmat-Ghahdarijani, et al.
Published: (2020-10-01)

Endothelial function changes in paroxysmal atrial fibrillation and treatment with propafenone
by: V. I. Podzolkov, et al.
Published: (2018-08-01)

Associations of aldosterone synthase gene polymorphism and atrial fibrillation affected by coronary heart disease in elderly and senile patients
by: L. I. Kudryavtseva, et al.
Published: (2019-10-01)

Relationship Between Endothelial Dysfunction and the Outcomes After Atrial Fibrillation Ablation
by: Keisuke Okawa, et al.
Published: (2023-06-01)

Coronary Endothelial Dysfunction Is Associated With Increased Risk of Incident Atrial Fibrillation
by: Michel T. Corban, et al.
Published: (2020-04-01)

IMPACT OF ANTICOAGULANT THERAPY ON THE INDICATORS OF ARTERIAL STIFFNESS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ATRIAL FIBRILLATION AFTER CARDIOEMBOLIC STROKE
by: I. A. Zolotovskaya, et al.
Published: (2016-12-01)

Aldosterone Antagonism in Atrial Fibrillation: Implications for AF‐Predominant HFpEF
by: Jennifer E. Ho
Published: (2020-09-01)

microRNAs as Biomarkers of Endothelial Dysfunction and Therapeutic Target in the Pathogenesis of Atrial Fibrillation
by: Vanessa Desantis, et al.
Published: (2023-03-01)

Pharmacological correction of plasma redox potential and endothelial dysfunction in ischemic heart failure
by: O. P. Donetskaya, et al.
Published: (2012-02-01)

Molecular Basis of Atrial Nitroso-Redox Imbalance in Permanent Human Atrial Fibrillation
by: Reilly, S, et al.
Published: (2009)

С(-344)Т polymorphism of aldosterone synthase gene, risk of metabolic syndrome, and atrial fibrillation risk for inhabitants of the Northwest regions of Russia
by: I. Ma, et al.
Published: (2016-06-01)

SUBCELLULAR, MOLECULAR AND SUBMOLECULAR MECHANISMS OF ALTERED CONTRACTILITY AND EFFICIENCY OF ENERGY TRANSFORMATION BY MYOCARDIAL MYOFIBRILS IN CHRONIC HEART FAILURE AND MODE OF ACTION OF CARDIAC GLYCOSIDES
by: N. V. Karsanov, et al.
Published: (2000-12-01)

Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects
by: Martina Bollati, et al.
Published: (2022-02-01)

EFFECT OF ARTERIAL HYPERTENSION ON LEFT VENTRICULAR GEOMETRIC REMODELING AND LEFT ATRIAL MECHANICAL DYSFUNCTION IN ATRIAL FIBRILLATION
by: M. Ya. Dotsenko, et al.
Published: (2022-06-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

Antiarrhythmic therapy choice in patients with left ventricular diastolic dysfunction and atrial fibrillation
by: A. V. Tarasov, et al.
Published: (1970-01-01)

New aspects of anticoagulant therapy in atrial fibrillation in patients with renal dysfunction
by: Zh. D. Kobalava, et al.
Published: (2020-12-01)

Cryptogenic stroke in atrial fibrillation without intra-heart thrombi: possible mechanisms
by: O. A. Germanova, et al.
Published: (2022-05-01)

Comparison of biomarkers of endothelial dysfunction and microvascular endothelial function in patients with primary aldosteronism and essential hypertension
by: Miaomiao Sang, et al.
Published: (2021-03-01)

Implications of SGLT Inhibition on Redox Signalling in Atrial Fibrillation
by: David Bode, et al.
Published: (2021-05-01)

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
by: Z. D. Kobalava, et al.
Published: (2021-03-01)

ATRIAL FIBRILLATION AND RENAL DYSFUNCTION: CURRENT STATE OF THE PROBLEM AND THE PROSPECTS OF FURTHER STUDY
by: K. V. Protasov, et al.
Published: (2016-04-01)

CLINICAL AND GENETIC PECULIARITIES OF ATRIAL FIBRILLATION
by: S. Y. Nikulina, et al.
Published: (2016-01-01)

Compromised redox homeostasis, altered nitroso-redox balance and therapeutic possibilities in atrial fibrillation
by: Simon, J, et al.
Published: (2016)

Atrial fibrillation in the patients with obesity and arterial hypertension
by: N. S. Tsyplenkova, et al.
Published: (2015-10-01)

GENETIC PREDICTORS OF ATRIAL FIBRILLATION
by: A. V. Kuskaeva, et al.
Published: (2016-06-01)

ATRIAL FIBRILLATION: FUNCTIONAL CLASSIFICATION
by: A. V. Germanov, et al.
Published: (2020-11-01)

Impact of renin–angiotensin–aldosterone-system inhibitor drugs on mortality in patients with atrial fibrillation and hypertension
by: Wei Xu, et al.
Published: (2022-04-01)

Rest and Stress Left Atrial Dysfunction in Patients with Atrial Fibrillation
by: Angela Zagatina, et al.
Published: (2023-09-01)

EPIDEMIOLOGY AND MANAGEMENT OF HEART FAILURE PATIENTS WITH ATRIAL FIBRILLATION
by: Y. F. OSMOLOVSKAYA, et al.
Published: (2016-12-01)

Correlation of oxidative stress and vascular endothelial dysfunction with hippocampal perfusion in atrial fibrillation patients with cognitive impairment
by: Hong hong Ke, et al.
Published: (2024-04-01)

Unveiling the Role of Endothelial Dysfunction: A Possible Key to Enhancing Catheter Ablation Success in Atrial Fibrillation
by: George E. Zakynthinos, et al.
Published: (2024-02-01)

Current Predictors of Atrial Fibrillation Progression
by: V. I. Podzolkov, et al.
Published: (2019-05-01)

CENTRAL HEMODYNAMIC PARAMETERS IN PATIENTS WITH IDIOPATHIC ATRIAL FIBRILLATION
by: K. V. trakhova, et al.
Published: (2011-06-01)

Drug-Induced Atrial Fibrillation / Atrial Flutter
by: O. D Ostroumova, et al.
Published: (2022-01-01)